Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma
Interventions: DRUG: Celecoxib
Sponsor: University of Wisconsin, Madison
Collaborators: National Cancer Institute (NCI)